Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immuneering (IMRX) Other Accumulated Expenses (2022 - 2024)

Historic Other Accumulated Expenses for Immuneering (IMRX) over the last 3 years, with Q3 2024 value amounting to $59657.0.

  • Immuneering's Other Accumulated Expenses fell 2588.92% to $59657.0 in Q3 2024 from the same period last year, while for Sep 2024 it was $59657.0, marking a year-over-year decrease of 2588.92%. This contributed to the annual value of $259770.0 for FY2023, which is 121223.48% up from last year.
  • As of Q3 2024, Immuneering's Other Accumulated Expenses stood at $59657.0, which was down 2588.92% from $90242.0 recorded in Q2 2024.
  • In the past 5 years, Immuneering's Other Accumulated Expenses registered a high of $259770.0 during Q4 2023, and its lowest value of $19796.0 during Q4 2022.
  • In the last 3 years, Immuneering's Other Accumulated Expenses had a median value of $47213.0 in 2022 and averaged $65931.8.
  • Over the last 5 years, Immuneering's Other Accumulated Expenses had its largest YoY gain of 121223.48% in 2023, and its largest YoY loss of 4422.51% in 2023.
  • Over the past 3 years, Immuneering's Other Accumulated Expenses (Quarter) stood at $19796.0 in 2022, then surged by 1212.23% to $259770.0 in 2023, then tumbled by 77.03% to $59657.0 in 2024.
  • Its last three reported values are $59657.0 in Q3 2024, $90242.0 for Q2 2024, and $23634.0 during Q1 2024.